DefiniGEN

DefiniGEN is a contract research organization (CRO) that specializes in liver and metabolic disease models using iPSC-derived technology. The company provides cell-based models for drug discovery and development.
  • Intestinal Organoids
  • Knock-In Cell Line Service
  • Knock-Out Cell Line Service
  • Opti-HEP: iPSC-derived Human Hepatocytes
  • Disease Models for MASLD, A1ATD, Wilson’s Disease, PFIC2, Urea Cycle disorders

Size
Small
Phone
+44 (0)1223497113
Email
Available in Endole App
Locations
Babraham Research Campus Moneta Building, B280, CB22 3AT
01223497113
9:00 - 17:30
Digital Popularity
Popularity over time
Social Media
Competitors
Stemnovate
Stemnovate is a pioneering company focused on building animal models for drug discovery in the pharmaceutical and animal health industries.
Company Details
DefiniGEN is operated by Pixl Bio Ltd and is a Active company incorporated on 7 April 2011 with the registered office located in Cambridge, Cambridgeshire. Pixl Bio Ltd was registered 14 years ago.

Status
Active
Size
Small
Directors
3
Age
14 years old
Employees
19
Turnover
Unreported
Total Assets
£1.89M
Cash in Bank
£593K
Total Liabilities
-£435K

Director • Ceo • Swedish • Lives in Sweden • Born in Mar 1977
Director • Cto • Swedish • Lives in Sweden • Born in Mar 1982
Director • Chief Business Officer • Austrian • Lives in Austria • Born in Apr 1991
Teams
All
26
Management
18
Research
8
Sales
4
Engineering
3
Finance
2
Other
1
Co-Founder CEO
Chief Executive Officer • Joined Jun 2021
Non Executive Director • Joined May 2023
Chief Business Officer • Joined Nov 2023
Logistics Manager • Joined Jul 2022
Marketing Manager • Joined Jun 2024
Marketing Manager
Non Executive Chair • Joined Jul 2024
Financial Director • Joined Apr 2024
Director Of Operations • Joined Nov 2022
Co-Founder CEO
Chief Executive Officer • Joined Jun 2021
Non Executive Director • Joined May 2023
Chief Business Officer • Joined Nov 2023
Logistics Manager • Joined Jul 2022
Marketing Manager • Joined Jun 2024
Marketing Manager
Non Executive Chair • Joined Jul 2024
Financial Director • Joined Apr 2024
Director Of Operations • Joined Nov 2022
Phd Researcher Assistant
Observer • Joined Jun 2023
Scientist II • Joined Jan 2022
Scientist II • Joined Oct 2021
Scientist III • Joined Jul 2022
Scientist II • Joined Oct 2022
Scientist • Joined Mar 2021
Senior Research Development Scientist
Head Of Research & Development • Joined Nov 2023
Senior Systems Analyst • Joined May 2021
Senior Research Development Scientist
Financial Director • Joined Apr 2024
Marketing Manager • Joined Jun 2024
Marketing Specialist • Joined Jun 2015
Director Of Business Development • Joined Aug 2019
Director Of Business Development - Europe • Joined May 2024
CRISPR Scientist • Joined Jan 2021
View 26 members